News

Boundless Bio's Upcoming Appearance at Healthcare Conference

Boundless Bio's Upcoming Appearance at Healthcare Conference

Boundless Bio's Participation in a Major Healthcare Conference

Boundless Bio, a pioneering clinical-stage oncology company, plans to participate in an important healthcare conference hosted by Piper Sandler. The company is focused on analyzing extrachromosomal DNA (ecDNA) biology, aiming to develop groundbreaking therapies for patients suffering from challenging oncogene amplified cancers.

Insights from the Conference Participation

Zachary Hornby, the President and CEO of Boundless Bio, is set to lead a fireside chat at Piper Sandler's 36th Annual Healthcare Conference. The session will take place on a Wednesday afternoon, a prime time for engagement with investors and collaborators. This platform will allow him to share insights and updates about the innovative approaches the company is adopting in oncology.

Live Webcast Details

For those interested in following this session, a live and archived webcast will be available. This provides an excellent opportunity for investors and interested parties to catch the session under the investment segment of Boundless Bio’s official website. These webcasts are a fantastic resource for staying updated with the latest developments in oncology research.

About Boundless Bio

Boundless Bio is on a mission to revolutionize cancer treatment. The company is specifically targeting extrachromosomal DNA (ecDNA), which significantly contributes to oncogene amplification in over 14% of cancer patients. With a focus on delivering effective therapies for these difficult cases, Boundless Bio presents a remarkable commitment toward addressing the unmet needs in oncology.

Innovative Therapies in Development

The company is advancing several therapies, including its first ecDNA-directed therapy, known as BBI-355. This oral inhibitor targets checkpoint kinase 1 (CHK1) and is currently undergoing Phase 1/2 clinical trials on patients with oncogene amplified tumors. Additionally, Boundless Bio is developing BBI-825, another oral therapy aimed at colorectal cancer patients featuring specific gene mutations. These innovative solutions showcase Boundless Bio's dedication to transforming treatment options available to oncologists and patients alike.

Groundbreaking Science and Future Goals

Boundless Bio continues to leverage its proprietary Spyglass platform, which is heavily invested in discovering new ecDNA-targeted therapies. An additional program, designated ecDTx 3, is also progressing through preclinical development stages. The ongoing research and innovation highlight Boundless Bio's position at the forefront of oncology therapeutics.

Contact Information

The company invites inquiries and provides a direct contact for interested parties. Reach out to Ben Flaum at Boundless Bio for further information about their projects and initiatives. Engaging with key representatives from the firm can lead to deeper insights into how they are impacting cancer research.

Frequently Asked Questions

What is Boundless Bio's main goal?

Boundless Bio aims to unlock new cancer therapies by targeting extrachromosomal DNA to help patients with oncogene amplified tumors.

Who is leading the discussion at the Piper Sandler Conference?

The discussion will be led by Zachary Hornby, the President and CEO of Boundless Bio.

How can I watch the conference session?

A webcast of the session will be available on Boundless Bio's website under their "Events & Presentations" section.

What therapies are currently in development by Boundless Bio?

Boundless Bio is developing BBI-355 and BBI-825, both targeting specific cancers and utilizing advanced ecDNA research.

How can I get in touch with Boundless Bio?

For inquiries, you can contact Ben Flaum at Boundless Bio or visit their website for more details.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 2

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 4

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 2

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

FGI Industries Reports Strong Q2 2025 Performance Metrics

Updated Category News Views 153

FGI Industries Financial Overview for Q2 2025 FGI Industries Ltd. (Nasdaq: FGI), a prominent supplier of kitchen and bath products, proudly announced its financial results for the second quarter of 2025, reflecting the company’s resilience amidst a challenging economic environment. Key Highlights from Q2 2025 In the second quarter of 2025, FGI reported total revenue of...

Continue Reading
Investigation into Soho House: Ensuring Fair Treatment for Shareholders

Updated Category News Views 158

Soho House Investigation by Ademi Firm The Ademi Firm is actively looking into Soho House & Co Inc. (NYSE: SHCO) concerning potential breaches of fiduciary duty related to its recent transaction to go private. This inquiry is essential to ensure that all public shareholders receive fair treatment as the company makes significant changes in its ownership structure. Details...

Continue Reading
Warren Buffett's Strategic Financial Moves and Stock Gains

Updated Category News Views 374

The Financial Journey of Warren Buffett Warren Buffett, the renowned investor, continues to showcase how strategic investments can yield impressive returns. His company, Berkshire Hathaway Inc (NYSE: BRK), has a significant presence in the financial sector, underscoring the potential of banking stocks. Buffett's Financial Investments Among the noteworthy investments in...

Continue Reading
AGAPE ATP Corporation Announces Reverse Stock Split

Updated Category News Views 61

AGAPE ATP Corporation Announces Reverse Stock Split AGAPE ATP Corporation (NASDAQ: ATPC) has filed a Certificate of Change with the Secretary of State of Nevada to implement a 1-for-20 reverse stock split of its common stock. This change will take effect on August 30, and the Company has shared the details in its filings with the Securities and Exchange Commission. After...

Continue Reading
Water System Partnerships: Community Impact and Insights

Updated Category News Views 8

Digging into Water System Partnerships Crack open a fresh perspective on municipal water system partnerships, courtesy of American Water's latest white paper. This isn't just a PR spiel—it's a deep dive into how these regulated systems can flip the script for resource-strapped municipalities, helping them tackle infrastructure headaches with some actual financial elbow...

Continue Reading